Hartley, John A.
Flynn, Michael J.
Bingham, John P.
Corbett, Simon
Reinert, Halla
Tiberghien, Arnaud http://orcid.org/0000-0002-2936-0515
Masterson, Luke A.
Antonow, Dyeison
Adams, Lauren
Chowdhury, Sajidah
Williams, David G.
Mao, Shenlan
Harper, Jay
Havenith, Carin E. G.
Zammarchi, Francesca
Chivers, Simon
van Berkel, Patrick H.
Howard, Philip W.
Funding for this research was provided by:
Cancer Research UK (C2559/A16569, C2559/A16569, C2559/A16569)
Article History
Received: 10 January 2018
Accepted: 22 June 2018
First Online: 11 July 2018
Competing Interests
: J.A.H., A.T., L.A.M., L.A., S.Cho., D.G.W. and P.W.H. are employees of Spirogen/Medimmune Limited. S.M. and J.H. are employees of MedImmune. P.H.v.B., F.Z., S.C.hi. and C.E.G.H. are employees of A.D.C. Therapeutics and P.H.v.B., J.A.H. and P.W.H. are also shareholders. The authors declare no non-financial competing interests.